Medications

India patent case threatens cheap drug supply: MSF

Supply of cheap, copycat drugs for the developing world could be badly threatened if Swiss firm Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.

Health

Gov't advisers: No copays for contraceptives

(AP) -- Millions of women stand to gain free access to a broad menu of birth control methods, thanks to a recommendation issued Tuesday by health experts advising the government.

Medications

Drug prescriptions confuse many users

When pharmacies, doctors' offices and homes were destroyed by the tornado in Joplin, Mo., so were the medication records of many patients. Pharmacists who helped out report that many people could not recall the names of their ...

Medications

A legal approach to reducing drug spending

In a new analysis published in the May issue of Health Affairs, Aaron Kesselheim, MD, JD, MPH, associate professor of medicine and director of the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology ...

Medications

FTC accuses Endo, other drugmakers of antitrust violations

The Federal Trade Commission has accused several drugmakers of violating antitrust laws, via agreements the commission said delayed the U.S. launches of cheaper generic versions of two popular pain treatments.

Medications

EU to slap big fine on French drugmaker Servier: sources

The EU is expected to inflict a heavy fine in the coming days on French drugs giant Servier for colluding to delay a cheaper version of a popular blood-pressure treatment, sources close to the matter told AFP on Tuesday.

Medications

Pfizer 2Q mixed, maintains 2013 outlook

Pfizer's second-quarter net income more than quadrupled, helped by the sale of its animal health business. The world's second-largest drugmaker beat Wall Street's earnings expectations, though revenue continued to decline ...

page 8 from 10